Establishing a national knowledge translation and generation network in kidney disease: The CAnadian KidNey KNowledge TraNslation and GEneration NeTwork

Canadian Journal of Kidney Health and Disease

Volumn 1, Issue 1, 2014, Pages 1-10

  Manns, Braden ^a,b   Barrett, Brendan ^c   Evans, Michael ^d   Garg, Amit ^e   Hemmelgarn, Brenda ^a,b   Kappe, Joanne ^f   Klarenbach, Scott ^g   Madore, Francois ^h   Parfrey, Patrick ^c   Samue, Susan ^b,i   Soroka, Steven ^j   Suri, Rita ^e,k   Tonelli, Marcello ^g   Wald, Ron ^l,m   Walsh, Michael ⁿ   Zappitelli, Michael ^o  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f UNIVERSITY OF SASKATCHEWAN   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

^h UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁱ ALBERTA CHILDREN S HOSPITAL RESEARCH INSTITUTE   (Canada)

^j DALHOUSIE UNIVERSITY   (Canada)

^k CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^l ST MICHAEL'S HOSPITAL   (Canada)

^m ST MICHAEL'S HOSPITAL   (Canada)

ⁿ MCMASTER UNIVERSITY   (Canada)

^o MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

more..

Author keywords

Clinical trials; Kidney disease; Knowledge translation

Indexed keywords

ALDOSTERONE ANTAGONIST;

CANADIAN KIDNEY KNOWLEDGE TRANSLATION AND GENERATION NETWORK; CHRONIC KIDNEY DISEASE; CLINICAL RESEARCH; DATA BASE; DECISION MAKING; DIALYSIS; HEALTH PROGRAM; HUMAN; KNOWLEDGE; MEDICAL SOCIETY; MORBIDITY; MORTALITY; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PEDIATRICS; PHOSPHATE BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 84991033012     PISSN: None     EISSN: 20543581     Source Type: Journal    
DOI: 10.1186/2054-3581-1-2     Document Type: Review

References (32)

1. Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzick, M, Burns K, Manns B, White C, Madore F, Moist L, Klarenbach S, Barrett B, Foley R, Jindal K, Senior P, Pannu N, Shurra, S, Akbari A, Cohn A, Reslerova M, Deved V, Mendelssohn D, Nesrallah G, Kappel J, Tonelli M: Guidelines for the management of chronic kidney disease. CMAJ 2008, 179:1154-1162.
2. Hemmelgarn B, Manns B, Lloyd A, James M, Klarenbach S, Quinn R, Wiebe K, Tonelli M: Relation between kidney function, Proteinuria, and adverse outcomes. JAMA 2010, 303:423-429.
3. James MT, Hemmelgarn BR, Tonelli M: Early recognition and prevention of chronic kidney disease. Lancet 2010, 375:1296-1309.
4. Strippoli GF, Craig JC, Schena FP: The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol 2004, 15:411-419.
5. Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kiberd BA: Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis 2001, 37:484-489.
6. Tonelli M, Gill J, Pandeya S, Bohm C, Levin A, Kiberd BA: Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency. Nephrol Dial Transplant 2002, 17:1426-1433.
7. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002, 137:555-562.
8. Burns K, Wolfs W, Belanger P, PE M: The KRESCENT Program: an initiative to match supply and demand for kidney research in Canada. Clin Invest Med 2010, 33:356-367.
9. Manns BJ, White CT, Madore F, Manns BJ, White CT, Madore F, Moist L, Klarenbach S, Barrett B, Foley R, Culleton B, Tonelli M: Introduction to the Canadian Society of Nephrology clinical practice guidelines for the management of anemia associated with chronic kidney disease. Kidney Int Suppl 2008:S1-S3.
10. Manns BJ, Hodsman A, Zimmerman DL, Mendelssohn D, Soroka S, Chan C, Jindal K, Klarenbach S: Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis 2010, 55:800-812.
11. Straus SE, Graham ID, Mazmanian PE: Knowledge translation: resolving the confusion. J Contin Educ Health Prof 2006, 26:3-4.
12. Graham ID, Logan J, Harrison MB, Straus S, Tetroe J, Caswell W, Robinson N: Lost in knowledge translation: time for a map? J Contin Educ Health Prof 2006, 26:13-24.
13. Cooper BA, Branley P, Bulfone L, Collins J, Craig JC, Fraenkel M, Harris A, Johnson D, Kesselhut J, Li J, Luxton G, Pilmore A, Tiller D, Harris DC, Pollock CA: A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010, 363:609-619.
14. Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group M: Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Annals of internal medicine 2013, 158:825-830.
15. Clark WF, Na YB, Rosansky SJ, Sontrop JM, Macnab JJ, Glassock RJ, Eggers PW, Jackson K, Moist L: Association between estimated glomerular filtration rate at initiation of dialysis and mortality. Can Med Assoc J 2011, 183:47-53.
16. National KF: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-S266.
17. Nesrallah G, Mustafa R, Clark W, Bass A, Barnieh L, Hemmelgarn BR, Klarenbach S, Quinn RR, Hiremath S, Ravani P, Sood MM, Moist LM: Canadian Society of Nephrology 2012 Clinical Practice Guideline for Timing the Initiation of Chronic Dialysis. CMAJ 2014, 186:112-117.
18. Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A: Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care 2005, 14:26-33.
19. Canadian Institute for Health Information: Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada 2001 to 2010. Ottawa, Ont; 2011.
20. Harwood L, Clark A: Understanding pre-dailysis modality decision-making: A meta-synthesis of qualitative studies. Int J Nurs Stud 2012: . In press.
21. Harwood L, Clark AM: Understanding pre-dialysis modality decision-making: a meta-synthesis of qualitative studies. Int J Nurs Stud 2013, 50:109-120.
22. Wuerth D, Finkelstein S, Schwetz O, Carey H, Kliger A, Finkelstein F: Patient's description of specific factors leading to modality selection of chronic peritoneal dialysis or hemodialysis. Periton Dialysis Int 2002, 22:184-190.
23. Golper T: Patient education: can it maximize the success of therapy. Nephrol Dial Transplant 2001, 16:20-24.
24. Morton RL, Howard K, Webster AC, Snelling P: Patient INformation about Options for Treatment (PINOT): a prospective national study of information given to incident CKD Stage 5 patients. Nephrol Dial Transplant 2011, 26:1266-1274.
25. Morton RL, Tong A, Howard K, Snelling P, Webster AC: The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. BMJ 2010, 340:c112.
26. Morton RL, Snelling P, Webster AC, Rose J, Masterson R, Johnson DW, Howard K: Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study. Am J Kidney Dis 2012, 60:102-111.
27. Quinn RR, Hux JE, Oliver MJ, Austin PC, Tonelli M, Laupacis A: Selection bias explains apparent differential mortality between dialysis modalities. J Am Soc Nephrol 2011, 22:1534-1542.
28. Merkus MP, Jager KJ, Dekker FW, De Haan RJ, Boeschoten EW, Krediet RT: Quality of life over time in dialysis: the Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int 1999, 56:720-778.
29. Foley RN, Parfrey PS, Harnett JD, Kent G, O'Dea R, Murray D, Barre P: Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol 1998, 9:267-276.
30. Collins AJ, Hao W, Xia H, Ebben J, Everson S, Constantini E, Ma J: Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999, 34:1065-1174.
31. Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Stevens P, Krediet RT: Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. Am J Kidney Dis 1997, 29:584-592.
32. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, Jeffery JR, Kjellstrand CM: Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997, 30:334-342.